AC Immune (ACIU) Share-based Compensation Growth (3y) (2018 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -34.72% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 4.80% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 10.78% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.55% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 20.65% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.02% |
| Sep 30, 2025 | 20.93% |
| Jun 30, 2025 | 13.29% |
| Mar 31, 2025 | 17.40% |
| Dec 31, 2024 | -0.87% |
| Sep 30, 2024 | -2.15% |
| Jun 30, 2024 | 18.89% |
| Mar 31, 2024 | 31.51% |
| Dec 31, 2023 | -6.97% |
| Sep 30, 2023 | -9.82% |
| Jun 30, 2023 | 9.80% |
| Mar 31, 2023 | 21.80% |
| Dec 31, 2022 | 4.21% |
| Sep 30, 2022 | -13.73% |
| Jun 30, 2022 | 18.52% |
| Mar 31, 2022 | 22.23% |
| Dec 31, 2021 | 22.01% |
| Sep 30, 2021 | 36.61% |
| Jun 30, 2021 | 8.26% |
| Mar 31, 2021 | 14.30% |
| Dec 31, 2020 | 26.02% |
| Sep 30, 2020 | -88.39% |
| Jun 30, 2020 | 71.98% |
| Mar 31, 2020 | 106.80% |
| Dec 31, 2019 | -5.53% |
| Sep 30, 2019 | 79.89% |
| Jun 30, 2019 | 75.75% |
| Mar 31, 2019 | 148.39% |
| Dec 31, 2018 | 121.27% |